Skip to main content

Advertisement

Log in

Non-motor and Extracerebellar Features in Spinocerebellar Ataxia Type 2

  • Original Paper
  • Published:
The Cerebellum Aims and scope Submit manuscript

Abstract

Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant degenerative disease. Pathological studies have demonstrated not only cerebellar and brainstem atrophy, but substantia nigra, motoneurons, basal ganglia, thalamus, and peripheral nerves involvement. These findings may explain non-motor and extra-cerebellar features in SCA2. We accessed the non-motor symptoms and extra-cerebellar signs in SCA2 patients in order to provide a better understanding on pathophysiological mechanisms and natural history of brain degeneration in the disease. Thirty-three SCA2 patients were evaluated and compared with 26 healthy subjects. We investigated the following variables: sleep disorders, cognitive deficit, olfactory impairment, urinary dysfunction, psychiatric symptoms, cramps, pain, movement disorders, and weight loss. SCA2 had a high frequency of REM sleep behavior disorder (48.48 %, N = 16) as well as excessive daytime sleepiness (42.42 %, N = 14). Chorea was present in 15.15 % (N = 5), dystonia in 27.27 % (N = 9), and parkinsonism in 27.27 % (N = 9). Slow saccadic pursuit was present in 87.87 % (N = 29) and ophtalmoparesis in 78.78 % (N = 26) of patients. Regarding sleep disorders, 18.18 % (N = 6) of patients had restless leg syndrome. Dysphagia was present in 39.39 % (N = 13), weight loss 24.24 % (N = 8), and urinary dysfunction 27.27 % (N = 9). Cramps was present in only 6 % of patients (N = 2). This study highlighted the high frequency of non-motor symptoms and extra-cerebellar signs in SCA2. Our findings demonstrate the widespread of nervous system involvement in SCA2 patients and contribute to better understand the natural history of brain degeneration in this genetic condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004;3:291–304.

    Article  PubMed  Google Scholar 

  2. Pedroso JL, França Jr MC, Braga-Neto P, D’Abreu A, Saraiva-Pereira ML, Saute JA, et al. Nonmotor and extracerebellar features in Machado-Joseph disease: a review. Mov Disord. 2013;28:1200–8.

    Article  PubMed  Google Scholar 

  3. Klinke I, Minnerop M, Schmitz-Hübsch T, Hendriks M, Klockgether T, Wüllner U, et al. Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6. Cerebellum. 2010;9:433–42.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rüb U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012;124:1–21.

    Article  CAS  PubMed  Google Scholar 

  5. Adanyeguh IM, Henry PG, Nguyen TM, Rinaldi D, Jauffret C, Valabregue R, et al. In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. Mov Disord. 2015;30:662–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Pedroso JL, Bor-Seng-Shu E, Felício AC, Braga-Neto P, Hoexter MQ, Teixeira MJ, et al. Substantia nigra echogenicity is correlated with nigrostriatal impairment in Machado-Joseph disease. Parkinsonism Relat Disord. 2013;19:742–5.

    Article  PubMed  Google Scholar 

  7. Maas RP, van Gaalen J, Klockgether T, van de Warrenburg BP. The preclinical stage of spinocerebellar ataxias. Neurology. 2015;85:96–103.

    Article  PubMed  Google Scholar 

  8. Pedroso JL, Bor-Seng-Shu E, Braga-Neto P, Ribeiro RS, Bezerra ML, do Prado LB, et al. Neurophysiological studies and non-motor symptoms prior to ataxia in a patient with Machado-Joseph disease: trying to understand the natural history of brain degeneration. Cerebellum. 2014;13:447–51.

    PubMed  Google Scholar 

  9. Lastres-Becker I, Rüb U, Auburger G. Spinocerebellar ataxia 2 (SCA2). Cerebellum. 2008;7:115–24.

    Article  CAS  PubMed  Google Scholar 

  10. Velázquez-Pérez L, Voss U, Rodríguez-Labrada R, Auburger G, Canales Ochoa N, Sánchez Cruz G, et al. Sleep disorders in spinocerebellar ataxia type 2 patients. Neurodegener Dis. 2011;8:447–54.

    Article  PubMed  Google Scholar 

  11. Valis M, Masopust J, Bažant J, Ríhová Z, Kalnická D, Urban A, et al. Cognitive changes in spinocerebellar ataxia type 2. Neuro Endocrinol Lett. 2011;32:354–9.

    PubMed  Google Scholar 

  12. Velázquez-Pérez L, Fernandez-Ruiz J, Díaz R, González RP, Ochoa NC, Cruz GS, et al. Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J Neurol. 2006;253:1165–9.

    Article  PubMed  Google Scholar 

  13. Magaña JJ, Velázquez-Pérez L, Cisneros B. Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives. Mol Neurobiol. 2013;47:90–104.

    Article  PubMed  Google Scholar 

  14. Velázquez-Pérez L, Rodríguez-Labrada R, Cruz-Rivas EM, Fernández-Ruiz J, Vaca-Palomares I, Lilia-Campins J, et al. Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease. Cerebellum. 2014;13:568–79.

    Article  PubMed  Google Scholar 

  15. de Castilhos RM, Furtado GV, Gheno TC, Schaeffer P, Russo A, Barsottini O, et al. Spinocerebellar ataxias in Brazil—frequencies and modulating effects of related genes. Cerebellum. 2014;13:17–28.

    Article  CAS  PubMed  Google Scholar 

  16. Braga-Neto P, Godeiro-Junior C, Dutra LA, Pedroso JL, Barsottini OG. Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA). Arq Neuropsiquiatr. 2010;68:228–30.

    Article  PubMed  Google Scholar 

  17. Schmitz-Hübsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008;71:982–9.

    Article  PubMed  Google Scholar 

  18. Stiasny-Kolster K, Mayer G, Schafer S, Möller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire a new diagnostic instrument. Mov Disord. 2007;22:2386–93.

    Article  PubMed  Google Scholar 

  19. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.

    CAS  PubMed  Google Scholar 

  20. Silveira-Moriyama L, Carvalho Mde J, Katzenschlager R, Petrie A, Ranvaud R, Barbosa ER, et al. The use of smell identification tests in diagnosis of Parkinson’s disease in Brazil. Mov Disord. 2008;16:2328–34.

    Article  Google Scholar 

  21. Rüb U, Farrag K, Seidel K, Brunt ER, Heinsen H, Bürk K, et al. Involvement of the cholinergic basal forebrain nuclei in spinocerebellar ataxia type 2 (SCA2). Neuropathol Appl Neurobiol. 2013;39:634–43.

    Article  PubMed  Google Scholar 

  22. Wu T, Wang C, Wang J, Hallett M, Zang Y, Chan P. Preclinical and clinical neural network changes in SCA2 parkinsonism. Parkinsonism Relat Disord. 2013;19:158–64.

    Article  PubMed  Google Scholar 

  23. Pedroso JL, de Freitas ME, Albuquerque MV, Saraiva-Pereira ML, Jardim LB, Barsottini OG. Should spinocerebellar ataxias be included in the differential diagnosis for Huntington’s diseases-like syndromes? J Neurol Sci. 2014;347:356–8.

    Article  PubMed  Google Scholar 

  24. van Gaalen J, Giunti P, van de Warrenburg BP. Movement disorders in spinocerebellar ataxias. Mov Disord. 2011;26:792–800.

    Article  PubMed  Google Scholar 

  25. Moro A, Munhoz RP, Moscovich M, Arruda WO, Raskin S, Teive HA. Movement disorders in spinocerebellar ataxias in a cohort of Brazilian patients. Eur Neurol. 2014;72:360–2.

    Article  PubMed  Google Scholar 

  26. Pedroso JL, Carvalho AA, Escorcio Bezerra ML, Braga-Neto P, Abrahão A, Albuquerque MV, et al. Unusual movement disorders in spinocerebellar ataxias. Parkinsonism Relat Disord. 2013;19:834–5.

    Article  PubMed  Google Scholar 

  27. Pedroso JL, Braga-Neto P, Felício AC, Minett T, Yamaguchi E, Prado LB, et al. Sleep disorders in Machado-Joseph disease: a dopamine transporter imaging study. J Neurol Sci. 2013;324:90–3.

    Article  CAS  PubMed  Google Scholar 

  28. Pedroso JL, Braga-Neto P, Felício AC, Aquino CC, Prado LB, Prado GF, et al. Sleep disorders in cerebellar ataxias. Arq Neuropsiquiatr. 2011;69:253–7.

    Article  PubMed  Google Scholar 

  29. Friedman JH, Fernandez HH, Sudarsky LR. REM behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3). Mov Disord. 2003;18:1520–2.

    Article  PubMed  Google Scholar 

  30. Moscovich M, Munhoz RP, Teive HA, Raskin S, Carvalho Mde J, Barbosa ER, et al. Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry. 2012;83:970–4.

    Article  PubMed  PubMed Central  Google Scholar 

  31. De Joanna G, De Rosa A, Salvatore E, Castaldo I, De Luca N, Izzo R, et al. Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. J Neurol Sci. 2008;275:60–3.

    Article  PubMed  Google Scholar 

  32. Sánchez-Cruz G, Velázquez-Pérez L, Gómez-Peña L, Martínez-Góngora E, Castellano-Sánchez G, Santos-Falcón N. Dysautonomic features in patients with Cuban type 2 spinocerebellar ataxia. Rev Neurol. 2001;33:428–34.

    PubMed  Google Scholar 

  33. Velázquez-Pérez L, Rodríguez-Labrada R, Canales-Ochoa N, Montero JM, Sánchez-Cruz G, Aguilera-Rodríguez R, et al. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study. Lancet Neurol. 2014;13:482–9.

    Article  PubMed  Google Scholar 

  34. Saute JA, Silva AC, Souza GN, Russo AD, Donis KC, Vedolin L, et al. Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients. Cerebellum. 2012;11:771–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Authors’ Contributions

1. Research project: A. Conception, B. Organization, C. Execution

2. Genetic evaluation: A. Execution

3. Clinical evaluation: A. Conception, B. Execution

4. Manuscript: A. Writing of the first draft, B. Review and Critique

Pedroso JL: 1A, 1B, 1C, 3A, 3B, 4A, 4B

Braga-Neto P: 1A, 1B, 1C, 3A, 3B, 4A, 4B

Bezerra MLE: 1A, 1B, 1C, 3A, 3B

Abrahão A: 1A, 1B, 1C, 3A, 3B

Albuquerque MVC: 1A, 1B, 1C, 3A, 3B

Rezende Filho FM: 3A, 3B, 4B

Souza PVS: 1A, 1B, 1C

Pinto WBVR: 1A, 1B, 1C

Borges Junior FRP: 1A, 1B, 1C, 3A, 3B

Saraiva-Pereira ML: 2A, 4A, 4B

Jardim LB: 2A, 4A, 4B

Barsottini OGP: 1A, 1B, 1C, 3A, 3B, 4A, 4B

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José Luiz Pedroso.

Ethics declarations

Full consent was obtained from the patients to be enrolled in this study. Our Institutional Ethics Committee approved this study.

Conflict of Interest

The authors declare that they have no competing interests.

Financial Disclosure

We have nothing to disclose.

Additional information

José Luiz Pedroso and Pedro Braga-Neto contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pedroso, J.L., Braga-Neto, P., Escorcio-Bezerra, M.L. et al. Non-motor and Extracerebellar Features in Spinocerebellar Ataxia Type 2. Cerebellum 16, 34–39 (2017). https://doi.org/10.1007/s12311-016-0761-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12311-016-0761-5

Keywords

Navigation